Experimental: Tezepelumab
D5180C00007
Phase 3 mab completed
Quick answer
Experimental: Tezepelumab for Asthma is a Phase 3 program (mab) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Asthma
- Phase
- Phase 3
- Modality
- mab
- Status
- completed